Acacetin Prevents Renal Damage Induced by Streptozotocin via Altering the NF‐κB/ASC/NLRP3 and AMPK/SIRT1 Pathways in Mice
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Qingfei Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shandong Provincial Third Hospital, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Sirtuin 1, AMP-Activated Protein Kinases, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Diabetic nephropathy (DN) is the most common cause of end‐stage renal disease. Its pathogenesis includes inflammation, an excess of reactive oxygen species, and kidney damage. The present study intended to explore the nephroprotective effects of acacetin (ACN) in streptozotocin‐induced diabetic animals. The following are the experimental groups: One millilitre of 0.9% saline was given to Group I (control), Streptozotocin (STZ) (diabetic animals) + 0.9% saline to Group II (DN group) (negative control), DN + ACN (15 mg/kg body weight [bw]) to Group III, and DN + Valsartan (150 mg/kg bw) to Group IV. According to the findings, ACN decreased the levels of glucose, serum creatinine (Scr), blood urea nitrogen (BUN), malondialdehyde (MDA), and proinflammatory cytokines while increasing the bw, superoxide dismutase (SOD), and glutathione peroxidase (GSH‐Px) in comparison to the DN animals. The histopathological analysis revealed that the animals treated with ACN showed recovery of renal damage in the tissues caused by STZ. In the STZ‐induced DN mice, ACN reduced renal damage by upregulating the proteins of 5′ adenosine monophosphate‐activated protein kinase (AMPK), p‐AMPK, and SIRT1 and downregulating the proteins of TGF‐β, COL‐1, COL‐IV, NF‐κB, ASC, NLRP3, and GSDMD, according to western blot analysis. Hence, the current study demonstrated that the regulation of the AMPK/SIRT1 and NF‐κB/ASC/NLRP3 inflammasome pathways in DN mice was responsible for the protective effects of ACN. ACN may therefore be a viable treatment option for DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shandong Provincial Third Hospital, Shandong University, Jinan, China.
- Department of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, India.
- Department of Nephrology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.
ORCID-Profile: Annamalai Vijayalakshmi, Meilan Zhou
Zitieren
APA
Yu, Q., Mao, H., Vijayalakshmi, A., & Zhou, M. (2025). Acacetin Prevents Renal Damage Induced by Streptozotocin via Altering the NF‐κB/ASC/NLRP3 and AMPK/SIRT1 Pathways in Mice. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2753
Vancouver
Yu Q, Mao H, Vijayalakshmi A, Zhou M. Acacetin Prevents Renal Damage Induced by Streptozotocin via Altering the NF‐κB/ASC/NLRP3 and AMPK/SIRT1 Pathways in Mice. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2753
BibTeX
@article{Yu2025,
author = {Yu, Qingfei and Mao, Hongyan and Vijayalakshmi, Annamalai and Zhou, Meilan},
title = {Acacetin Prevents Renal Damage Induced by Streptozotocin via Altering the NF‐κB/ASC/NLRP3 and AMPK/SIRT1 Pathways in Mice},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2753}
}
EUVIMED